A new compound has been shown to block a protein essential for the growth of many cancers. Australian researchers who collaborated with industry partner Servier included (L-R): Dr Gemma Kelly, Professor Andrew Roberts (both Walter and Eliza Hall Institute), Associate Professor Andrew Wei (The Alfred Hospital), Professor David Huang, Dr Jianan Gong, Associate Professor Guillaume Lessene (all Walter and Eliza Hall Institute), and Dr Donia Moujalled (The Alfred Hospital)
A new compound, discovered jointly by international pharmaceutical company Servier, France, and Vernalis (R&D),UK, has been shown by researchers at the Walter and Eliza Hall Institute and Servier to block a protein that is essential for the sustained growth of up to a quarter of all cancers...
Read More
Recent Comments